Genes in plain terms
Almost every cell in the body carries a copy of the same set of DNA, the molecule that stores biological instructions. Stretches of DNA called genes typically contain the instructions for making proteins, which do much of the work in cells. The full set of DNA is called the genome. People share the large majority of their DNA, and the differences between individuals are a small fraction of the whole, yet those differences help explain why people vary in traits and in how they respond to illness.
This article is general information, not medical advice. Questions about your own family history or test results are best discussed with a clinician or genetic counselor.
How inheritance works
You receive DNA from both biological parents, roughly half from each. Some traits and conditions follow fairly simple patterns:
- Dominant patterns. One altered copy of a gene is enough to have an effect.
- Recessive patterns. Two altered copies, one from each parent, are needed. A person with one copy may be a carrier and show no signs.
- Sex-linked patterns. The gene sits on a sex chromosome, so the pattern differs between males and females.
Many common conditions, such as heart disease or type 2 diabetes, are not like this. They involve many genes with small effects interacting with diet, activity, environment and chance. Having a genetic variant that raises risk is not the same as being destined to develop a condition, and the reverse is also true.
Changes in DNA, called variants or mutations, can be inherited or can arise during life. Some are harmless, some matter greatly and many are of uncertain significance. That last category is a real source of confusion in testing.
How genetic knowledge is used in medicine
Several practical uses are well established.
- Diagnosis. Testing can help identify the cause of a condition, especially rare diseases that appear in childhood. Finding a cause can end a long search and guide care.
- Carrier and prenatal screening. Prospective parents may be offered tests to learn whether they carry variants that could affect a child. Choices that follow are deeply personal.
- Newborn screening. Many places screen babies for certain conditions so treatment can begin early. Which conditions are included differs by region.
- Risk assessment. For some inherited cancers and other conditions, results can inform screening schedules or preventive measures, which connects to the work described under cancer research.
- Drug response. The field of pharmacogenomics studies how genetic differences influence how people process certain medicines, which may help guide dose or choice in some situations.
Each of these has limits. A test looks for specific things; a negative result does not rule out every possibility.
Toward personalized care
The hope is that knowing more about a person’s genes, alongside lifestyle and other information, could help match prevention and treatment to the individual. This idea, discussed in more depth under personalized medicine, is already used in some cancer treatments that depend on features of a tumor’s DNA. In other areas it is still early. Evidence that genetic information improves outcomes has to be gathered condition by condition.
Direct-to-consumer tests
Some companies sell DNA tests directly to the public for ancestry or health information. These can be interesting, but there are cautions. Health-related results may cover only a few variants, may not be validated to clinical standards and can be hard to interpret without context. Unexpected results, such as a hint of a serious risk or of unknown family relationships, can be upsetting. Many people choose to talk to a professional before and after testing.
Ethical questions
Genetic information is unusual because it is personal and also shared with relatives. That raises several issues.
- Privacy. DNA data is hard to make truly anonymous. Who stores it, who may access it and how it could be used by researchers, employers or insurers are ongoing debates tied to wider concerns about online privacy. Many countries have laws that limit genetic discrimination, but protections differ.
- Consent and the right not to know. Some people want all available information; others prefer not to learn about risks they cannot change.
- Family impact. One person’s result may have implications for siblings or children who did not choose to be tested.
- Fairness. Most genetic studies have historically included more people of European ancestry, which can make results less accurate for others. Broader research is meant to correct this.
- Editing the genome. Technologies that change DNA raise special questions, particularly about changes that could be inherited, as discussed in germline editing.
Genes are not destiny
A common misunderstanding is that genes determine everything. In reality, environment, behavior and chance shape health alongside DNA, and the study of how this works is still developing. Reading the genome is also different from understanding it; scientists are still learning what many variants do.
What to expect
In the coming years genetic information is likely to become a more routine part of care, with sequencing used more often and interpreted with help from data tools. How quickly that happens, who benefits and how privacy is protected will depend on evidence, regulation and public discussion. For now, a balanced view treats genetics as a powerful but partial source of information.